Showing results 1 to 20 of 24
next >
| Rights | Preview | Issue Date | Title | Author(s) | Type |
| openAccess |  | 18-Dec-2019 | A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors | Pérez-Peña, Javier; Tibor Fekete, Janos; Páez, Raquel; Baliu-Piqué, Mariona; García-Saenz, José Ángel; García-Barberán, Vanesa; Manzano, Aránzazu; Pérez-Segura, Pedro; Esparís-Ogando, Azucena  ; Pandiella, Atanasio ; Győrffy, Balázs; Ocaña, Alberto | artículo |
| closedAccess |  | 2005 | Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin | Yuste, Laura; Montero, Juan Carlos ; Esparís-Ogando, Azucena ; Pandiella, Atanasio | artículo |
| closedAccess |  | 2012 | Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer | Montero, Juan Carlos ; Esparís-Ogando, Azucena ; Re-Louhau, M. F. ; Seoane, Samuel ; Abad, María del Mar; Calero, R.; Ocaña, Alberto; Pandiella, Atanasio | artículo |
| openAccess |  | 30-Aug-2019 | Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer | Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Burgos, Miguel; Gómez-Juárez, Mónica; Montero, Juan Carlos ; Esparís-Ogando, Azucena ; Pandiella, Atanasio ; Galán-Moya, Eva María; Ocaña, Alberto | artículo |
| closedAccess |  | 1999 | Cleavage of the TrkA neurotrophin receptor by multiple metalloproteases generates signalling-competent truncated forms | Díaz-Rodríguez, Elena ; Cabrera, Noemí ; Esparís-Ogando, Azucena ; Montero, Juan Carlos ; Pandiella, Atanasio | artículo |
| closedAccess |  | 2000 | Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-α-converting enzyme | Montero, Juan Carlos ; Yuste, Laura; Díaz-Rodríguez, Elena ; Esparís-Ogando, Azucena ; Pandiella, Atanasio | artículo |
| openAccess |  | 1-Jul-2009 | ERK2, but Not ERK1, Mediates Acquired and “De novo” Resistance to Imatinib Mesylate: Implication for CML Therapy | Aceves-Luquero, Clara I.; Esparís-Ogando, Azucena ; Pandiella, Atanasio | artículo |
| closedAccess |  | 2007 | Erk5 nuclear location is independent on dual phosphorylation, and favours resistance to TRAIL-induced apoptosis | Borges, Joana; Pandiella, Atanasio ; Esparís-Ogando, Azucena | artículo |
| closedAccess |  | Jan-2002 | Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2 | Esparís-Ogando, Azucena ; Díaz-Rodríguez, Elena ; Montero, Juan Carlos ; Yuste, Laura; Crespo, Piero ; Pandiella, Atanasio | artículo |
| openAccess |  | 2013 | ERK5/BMK1 is a novel target of the tumor suppressor VHL: Implication in clear cell renal carcinoma | Esparís-Ogando, Azucena ; Prado, Alfonso; Pandiella, Atanasio ; Peso, Luis del; Sánchez-Prieto, Ricardo | artículo |
| openAccess |  | 15-May-2009 | Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target | Montero, Juan Carlos ; Ocaña, Alberto; Abad, María del Mar; Ortiz-Ruiz, María Jesús ; Pandiella, Atanasio ; Esparís-Ogando, Azucena | artículo |
| closedAccess | | 1-Jun-2005 | Multifunctional role of Erk5 in multiple myeloma | Carvajal-Vergara, Xonia; Tabera, Soraya; Montero, Juan C; Esparís-Ogando, Azucena ; López-Pérez, Ricardo ; Mateo, Gema; Gutiérrez, Norma C.; Parmo-Cabañas, Marisa ; Teixidó, Joaquín ; San Miguel, Jesús F; Pandiella, Atanasio | artículo |
| openAccess |  | 2016 | Neuregulin expression in solid tumors: Prognostic value and predictive role to anti-HER3 therapies | Ocaña, Alberto; Díez-González, Laura; Esparís-Ogando, Azucena ; Montero, Juan Carlos ; Amir, Eitan; Pandiella, Atanasio | artículo |
| closedAccess |  | 2008 | Neuregulins and Cancer | Montero, Juan Carlos ; Rodríguez-Barrueco, Ruth; Ocaña, Alberto; Díaz-Rodríguez, Elena ; Esparís-Ogando, Azucena ; Pandiella, Atanasio | artículo |
| openAccess |  | 2017 | ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA | Talamillo, Ana; Grande, Lara; Ruiz Ontañón, Patricia; Velásquez, Carlos; Mollinedo, Pilar; Aznar, Ángela; Esparís-Ogando, Azucena ; López-López, Carlos; Lafita, M. Carmen ; Berciano, María T.; Montero, Juan A.; Vázquez-Barquero, Alfonso; Segura, Víctor; Villagra, Nuria T.; Pandiella, Atanasio ; Lafarga, Miguel; León, Javier ; Martínez-Climent, José Ángel; Sanz-Moreno, Victoria; Fernández-Luna, J. L. | artículo |
| closedAccess |  | 2005 | Overexpression of RasN17 fails to neutralize endogenous ras in MCF7 breast cancer cells | Yuste, Laura; Esparís-Ogando, Azucena ; Santos de Dios, Eugenio ; Pandiella, Atanasio | artículo |
| closedAccess |  | 2013 | Potent antimyeloma activity of a novel ERK5/CDK inhibitor | Álvarez-Fernández, Stela ; Ortiz-Ruiz, María Jesús ; Parrott, Tracy; Zaknoen, Sara; Ocio, Enrique M. ; San Miguel, Jesús F. ; Burrows, Francis J.; Esparís-Ogando, Azucena ; Pandiella, Atanasio | artículo |
| openAccess |  | 4-Mar-2019 | Resistance to MAPK inhibitors in melanoma involves activation of the IGF-1R-MEK5-Erk5 pathway | Benito-Jardón, Lucía; Díaz-Martínez, Marta; Arellano-Sánchez, Nohemí ; Vaquero-Morales, Paloma; Esparís-Ogando, Azucena ; Teixidó, Joaquín | artículo |
| closedAccess |  | 2008 | Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells | Esparís-Ogando, Azucena ; Ocaña, Alberto; Rodríguez-Barrueco, Ruth; Ferreira, Laura; Borges, Joana; Pandiella, Atanasio | artículo |
| closedAccess |  | 2016 | Targeting the EGF/HER ligand-receptor system in cancer | Esparís-Ogando, Azucena ; Montero, Juan Carlos ; Arribas, Joaquín; Ocaña, Alberto; Pandiella, Atanasio | artículo |
